These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27012016)

  • 1. Life-threatening Reaction to Iron Dextran: Protocol for Induction of Tolerance.
    Cardona R; Sánchez J; Ramírez R
    J Investig Allergol Clin Immunol; 2016; 26(1):48-9. PubMed ID: 27012016
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction of penicillin tolerance in therapy of neurosyphilis in penicillin allergy].
    Regele D; Ruëff F; Degitz K; Przybilla B
    Hautarzt; 1999 Mar; 50(3):194-7. PubMed ID: 10231689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.
    Demir S; Olgac M; Saglam S; Gelincik A; Colakoglu B; Buyukozturk S
    J Investig Allergol Clin Immunol; 2016; 26(1):66-7. PubMed ID: 27012024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parenteral iron therapy: problems and possible solutions].
    Hoigné R; Breymann C; Künzi UP; Brunner F
    Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.
    Auerbach M; Al Talib K
    Kidney Int; 2008 Mar; 73(5):528-30. PubMed ID: 18274543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe administration of iron dextran to a patient who reacted to the test dose.
    Monaghan MS; Glasco G; St John G; Bradsher RW; Olsen KM
    South Med J; 1994 Oct; 87(10):1010-2. PubMed ID: 7939912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
    Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding a safe and effective intravenous iron treatment for restless legs syndrome.
    Auerbach M
    Sleep Med; 2010 May; 11(5):429-30. PubMed ID: 20371211
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful Rapid Desensitization to Glatiramer Acetate in a Patient With Multiple Sclerosis.
    Syrigou E; Psarros P; Grapsa D; Syrigos K
    J Investig Allergol Clin Immunol; 2015; 25(3):214-5. PubMed ID: 26182688
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful Desensitization to Vitamin D in a Patient With Vitamin D Deficiency.
    Unal D; Coskun R; Demir S; Gelincik A; Colakoglu B; Buyukozturk S
    J Investig Allergol Clin Immunol; 2016; 26(6):392-393. PubMed ID: 27996953
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran.
    Freter S; Davidman M; Lipman M; Bercovitch D
    Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical update: intravenous iron for anaemia.
    Auerbach M; Ballard H; Glaspy J
    Lancet; 2007 May; 369(9572):1502-1504. PubMed ID: 17482969
    [No Abstract]   [Full Text] [Related]  

  • 13. Concerns expressed regarding total dose infusion article--February 1998 issue.
    Helenek MJ
    ANNA J; 1998 Aug; 25(4):378. PubMed ID: 9791308
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.
    Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M
    Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient power elevation during iron dextran infusion in a patient with a continuous-flow left ventricular assist device.
    Alvarez PA; Byram N; Williams JB; Jacob M; Kreiss M; Fukamachi K; Moazami N
    Int J Artif Organs; 2019 Jun; 42(6):318-320. PubMed ID: 30556439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients.
    Sinha S; Chiu D; Peebles G; Swoboda P; Kolakkat S; Lamerton E; Fenwick S; Bhandari S; Kalra PA
    QJM; 2011 Mar; 104(3):221-30. PubMed ID: 20956457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower molecular weight intravenous iron dextran for restless legs syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2013 Mar; 14(3):274-7. PubMed ID: 23333678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron dextran for severe refractory restless legs syndrome.
    Ondo WG
    Sleep Med; 2010 May; 11(5):494-6. PubMed ID: 20371212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should intravenous iron be upfront therapy for iron deficiency anemia?
    Auerbach M
    Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous iron administration in a short-stay hospital setting.
    Peebles G; Fenwick S
    Nurs Stand; 2008 Aug 6-12; 22(48):35-41. PubMed ID: 18727354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.